KEAP1 is a negative regulator of NRF1 and NRF2, and NRF1/NRF2 downregulation leads to a reduced expression of antioxidant genes and increased ROS levels, triggering anti-MM activity [64]. The gene discussed is NRF1; the disease is Miyoshi myopathy.